| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |